These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34619382)

  • 1. SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.
    Coolen JPM; Wolters F; Tostmann A; van Groningen LFJ; Bleeker-Rovers CP; Tan ECTH; van der Geest-Blankert N; Hautvast JLA; Hopman J; Wertheim HFL; Rahamat-Langendoen JC; Storch M; Melchers WJG
    J Clin Virol; 2021 Nov; 144():104993. PubMed ID: 34619382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays.
    Borillo GA; Kagan RM; Marlowe EM
    Front Cell Infect Microbiol; 2022; 12():894613. PubMed ID: 35619652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Concern.
    Xiong D; Zhang X; Shi M; Wang N; He P; Dong Z; Zhong J; Luo J; Wang Y; Yu J; Wei H
    Microbiol Spectr; 2022 Feb; 10(1):e0143821. PubMed ID: 34985323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory.
    Lind A; Barlinn R; Landaas ET; Andresen LL; Jakobsen K; Fladeby C; Nilsen M; Bjørnstad PM; Sundaram AYM; Ribarska T; Müller F; Gilfillan GD; Holberg-Petersen M
    J Clin Virol; 2021 Aug; 141():104906. PubMed ID: 34273860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combining epidemiological data and whole genome sequencing to understand SARS-CoV-2 transmission dynamics in a large tertiary care hospital during the first COVID-19 wave in The Netherlands focusing on healthcare workers.
    Haanappel CP; Oude Munnink BB; Sikkema RS; Voor In 't Holt AF; de Jager H; de Boever R; Koene HHHT; Boter M; Chestakova IV; van der Linden A; Molenkamp R; Osbak KK; Arcilla MS; Vos MC; Koopmans MPG; Severin JA
    Antimicrob Resist Infect Control; 2023 May; 12(1):46. PubMed ID: 37165456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of analytical performance and economic value of two biosurveillance methods for tracking SARS-COV-2 variants of concern.
    Pinkhover NP; Pontbriand KM; Fletcher KP; Sanchez E; Okello K; Garvey LM; Pum A; Li K; DeOliveira G; Proctor T; Feenstra JDM; Sorel O; Gandhi M; Auclair JR
    Microbiol Spectr; 2024 Feb; 12(2):e0348423. PubMed ID: 38206048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis.
    Bull RA; Adikari TN; Ferguson JM; Hammond JM; Stevanovski I; Beukers AG; Naing Z; Yeang M; Verich A; Gamaarachchi H; Kim KW; Luciani F; Stelzer-Braid S; Eden JS; Rawlinson WD; van Hal SJ; Deveson IW
    Nat Commun; 2020 Dec; 11(1):6272. PubMed ID: 33298935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of intra-hospital SARS-CoV-2 transmission using nanopore whole-genome sequencing.
    Løvestad AH; Jørgensen SB; Handal N; Ambur OH; Aamot HV
    J Hosp Infect; 2021 May; 111():107-116. PubMed ID: 33647375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated transmission of SARS-CoV-2 in an overcrowded Irish emergency department elucidated by whole-genome sequencing.
    Hare D; Meaney C; Powell J; Slevin B; O' Brien B; Power L; O' Connell NH; De Gascun CF; Dunne CP; Stapleton PJ
    J Hosp Infect; 2022 Aug; 126():1-9. PubMed ID: 35562074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RT-PCR genotyping assays to identify SARS-CoV-2 variants in England in 2021: a design and retrospective evaluation study.
    Bray N; Sopwith W; Edmunds M; Vansteenhouse H; Feenstra JDM; Jacobs P; Rajput K; O'Connell AM; Smith ML; Blomquist P; Hatziioanou D; Elson R; Vivancos R; Gallagher E; Wigglesworth MJ; Dominiczak A; Hopkins S; Lake IR
    Lancet Microbe; 2024 Feb; 5(2):e173-e180. PubMed ID: 38244555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic surveillance of SARS-CoV-2 in the Republic of Congo.
    Ntoumi F; Mfoutou Mapanguy CC; Tomazatos A; Pallerla SR; Linh LTK; Casadei N; Angelov A; Sonnabend M; Peter S; Kremsner PG; Velavan TP
    Int J Infect Dis; 2021 Apr; 105():735-738. PubMed ID: 33737129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid and Flexible RT-qPCR Surveillance Platforms To Detect SARS-CoV-2 Mutations.
    Spiess K; Gunalan V; Marving E; Nielsen SH; Jørgensen MGP; Fomsgaard AS; Nielsen L; Alfaro-Núñez A; Karst SM; ; Mortensen S; Rasmussen M; Lassaunière R; Rosenstierne MW; Polacek C; Fonager J; Cohen AS; Nielsen C; Fomsgaard A
    Microbiol Spectr; 2023 Feb; 11(1):e0359122. PubMed ID: 36625603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a characteristic melting profile of a SARS-CoV-2 Kappa variant in Italy using the SARS-CoV-2 Variants ELITe MGB® Kit.
    Scapaticci M; Bartolini A; Vitone F; Cerreta V; Vignoli M; Gnudi E; Frazzoni A; Sitta B; Capitani S; Lopriore A; Donadio M; Chiarastella S; Bioli M; Mancini R
    J Virol Methods; 2022 Mar; 301():114458. PubMed ID: 35026304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular biology of SARS-CoV-2 and techniques of diagnosis and surveillance.
    Ishige T
    Adv Clin Chem; 2024; 118():35-85. PubMed ID: 38280807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of an outbreak of symptomatic SARS-CoV-2 VOC 202012/01-lineage B.1.1.7 infection in healthcare workers, Italy.
    Loconsole D; Sallustio A; Accogli M; Leaci A; Sanguedolce A; Parisi A; Chironna M
    Clin Microbiol Infect; 2021 Aug; 27(8):1174.e1-1174.e4. PubMed ID: 33984489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
    Liu H; Li J; Lin Y; Bo X; Song H; Li K; Li P; Ni M
    J Med Virol; 2022 Jan; 94(1):327-334. PubMed ID: 34524690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 Whole-Genome Sequencing by Ion S5 Technology-Challenges, Protocol Optimization and Success Rates for Different Strains.
    Szargut M; Cytacka S; Serwin K; Urbańska A; Gastineau R; Parczewski M; Ossowski A
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of SARS-CoV-2 genomic epidemiology reveals disease transmission coupled to variant emergence and allelic variation.
    Bandoy DJDR; Weimer BC
    Sci Rep; 2021 Apr; 11(1):7380. PubMed ID: 33795722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants.
    Chaki SP; Kahl-McDonagh MM; Neuman BW; Zuelke KA
    Microbiol Spectr; 2022 Jun; 10(3):e0066522. PubMed ID: 35638906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.